Mária P.
- Country
- Germany
- Department
- Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 29 partner sites.
Specializations
Pediatric Oncology
This investigator specializes in treating rare pediatric cancers, with particular focus on ALK-positive anaplastic large cell lymphoma (ALCL) in children and adolescents. Their research explores therapeutic approaches using targeted treatments in standard-risk cases.
- ALK-positive lymphoma management
- Pediatric cancer therapy
- Standard risk ALCL treatment
The investigator's work emphasizes long-term therapeutic strategies for pediatric lymphoma patients.
Neuroblastoma Research
The investigator focuses on developing treatment strategies for low and intermediate risk neuroblastoma. Their expertise extends to risk-based treatment approaches and personalized therapy protocols based on genetic markers.
- Risk stratification methods
- Gene expression analysis
- Treatment optimization
Their work involves evaluating treatment intensification and reduction strategies based on patient risk profiles.
Clinical Innovation
The investigator advances personalized medicine approaches in pediatric oncology through multicenter clinical research. Their work encompasses treatment stratification and survival outcome improvement strategies.
- Risk-adapted therapy
- Treatment stratification
- Event-free survival optimization
Their research aims to enhance treatment outcomes while optimizing therapeutic approaches for pediatric cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.